FDA Approves Encorafenib Plus Binimetinib Combination for Non-Small Cell Lung Cancer

Retrieved on: 2023-10-12 17:07:50

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Encorafenib Plus Binimetinib Combination for Non-Small Cell Lung Cancer. View article details on hiswai:

Excerpt

Encorafenib (Braftovi; Pfizer Inc) and binimetinib (Mektovi; Pfizer Inc) approved for the treatment of patients with metastatic non-small cell ...

Article found on: www.pharmacytimes.com